Kalindi Parmar
4PUBLICATIONS
65CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Feb 13, 2026
A Phase II Trial of Niraparib in Patients with Advanced Pancreatic Cancer Harboring Pathogenic Variants in ATM, BRCA1, BRCA2, PALB2, and CHEK2.Brandon M Huffman, Miklos Diossy, Matthew B Yurgelun
|Jun 17, 2024
Single-Stranded DNA Gap Accumulation Is a Functional Biomarker for USP1 Inhibitor Sensitivity.Alexandre A da Costa, Ozge Somuncu, Ramya Ravindranathan
|Oct 11, 2023
A Phase I Expansion Cohort Study Evaluating the Safety and Efficacy of the CHK1 Inhibitor LY2880070 with Low-dose Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma.Brandon M Huffman, Hanrong Feng, Kalindi Parmar
|Aug 16, 2022
Targeting DNA Repair with Combined Inhibition of NHEJ and MMEJ Induces Synthetic Lethality in TP53-Mutant Cancers.Jeffrey Patterson-Fortin, Arindam Bose, Wei-Chih Tsai
Pageof 1
Frequent Collaborators
4 joint publications
Geoffrey I Shapiro
4 joint publications
Alan D D'Andrea
3 joint publications
Huy Nguyen
2 joint publications
David B Martignetti
2 joint publications
Bose S Kochupurakkal
2 joint publications
Leah H Biller
2 joint publications
Golbahar Sadatrezaei
2 joint publications
Jean-Bernard Lazaro
2 joint publications
Joyce Liu
2 joint publications
Brandon M Huffman
